Lin Yu-Hsin
- SEC CIK
- 0001965964
In the past year, 3 open-market sale filings worth $20.8M and no purchases.
Current role at each company
- BLTE Belite Bio, IncChief Executive Officeras of Sep 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $20.8M
- 3 filings
- Net
- −$20.8M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lin Yu-Hsin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 (view filing)7:39 PM ET | Sep 4-8 | 5 days | Lin Yu-HsinChief Executive Officer | SSaleAmerican depositary share | −100.4K | $190.00 | −$19.1M | −58.9%70.1K after | 19 lots10b5-1 |
| Aug 14, 2026 (view filing)6:10 AM ET | Aug 12 | 2 days | Lin Yu-HsinChief Executive Officer | SSaleAmerican depositary share | −365 | $180.35 | −$65.8K | −0.2%170.6K after | 2 lots10b5-1 |
| Apr 13, 2026 (view filing) | Apr 9 | 4 days | Lin Yu-HsinChief Executive Officer | SSaleAmerican depositary share | −9.20K | $181.45 | −$1.67M | −5.1%170.9K after | 4 lots10b5-1 |